Table 2.
Univariate and multivariate analyses for patient overall survival
| Risk factor | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| HR | p-Value | 95% CI | HR | p-Value | 95% CI | |
| PPT2 expression | 0.712 | 0.030 | 0.525-0.967 | 0.942 | 0.047 | 0.687-1.292 |
| Age | 1.771 | 0.000 | 1.298-2.416 | 1.670 | 0.002 | 1.215-2.295 |
| Gender | 0.940 | 0.700 | 0.688-1.285 | 0.912 | 0.570 | 0.662-1.225 |
| Metastasis | 4.275 | 0.000 | 3.128-5.843 | 2.454 | 0.000 | 1.661-3.625 |
| T stage | 3.033 | 0.000 | 2.232-4.121 | 0.938 | 0.842 | 0.501-1.757 |
| TNM stage | 3.639 | 0.000 | 2.645-5.006 | 2.106 | 0.045 | 1.018-4.354 |
| G stage | 2.559 | 0.000 | 1.820-3.600 | 1.631 | 0.009 | 1.131-2.353 |
HR, hazard ratio, estimated from Cox proportional hazard regression model; CI, confidence interval of the estimated HR.